Real-World Patients with Cancer Show Lower Survival Times and Treatment-Associated Survival Benefits Compared to Those Included in RCTs

Findings from machine learning-based and population-level electronic health record data-based emulation of landmark phase III randomised clinical trials in oncology

Source